← Leaderboards
Michael J Smanski
Metselex, Inc.
$1,119,272
Attributed
$3,357,817
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,357,817 · 2
By mechanism
R42$2,907,583 · 1
R41$450,234 · 1
Top collaborators
- Walter C Low4 shared
- Gunda I. Georg3 shared
- Dezhi Liao1 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposChronicApp-Ps1CholesterolAcuteAmyloid Precursor Protein ProcessingCare CostsAnabolismCell DeathCellsAmyloid Beta-ProteinAnimalsApoptosis InhibitorApoptoticCholic AcidsArtemiaBacteriaAnalogBile AcidsAnalytical MethodAbateCause Of DeathBusinessesCombat
Grant awards (4)
Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease$283,246
R42 · FY2025 · AG · contact PI
Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease$1,280,101
R42 · FY2024 · AG · contact PI
Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease$1,344,236
R42 · FY2023 · AG · contact PI
Microbial Synthesis of Therapeutic Bile Acids$450,234
R41 · FY2020 · NS · contact PI